|
1
|
Sabbah HN and Sharov VG: Apoptosis in
heart failure. Prog Cardiovasc Dis. 40:549–562. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mill JG, Stefanon I, dos Santos L and
Baldo MP: Remodeling in the ischemic heart: the stepwise
progression for heart failure. Braz J Med Biol Res. 44:890–898.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takemura G and Fujiwara H: Role of
apoptosis in remodeling after myocardial infarction. Pharmacol
Ther. 104:1–16. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hausenloy DJ and Yellon DM: Myocardial
ischemia-reperfusion injury: A neglected therapeutic target. J Clin
Invest. 123:92–100. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jeong H, Yim HW, Cho Y, Park HJ, Jeong S,
Kim HB, Hong W and Kim H: The effect of rigorous study design in
the research of autologous bone marrow-derived mononuclear cell
transfer in patients with acute myocardial infarction. Stem Cell
Res Ther. 4:822013. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fisher SA, Dorée C, Brunskill SJ, Mathur A
and Martin-Rendon E: Bone marrow stem cell treatment for ischemic
heart disease in patients with no option of revascularization: A
systematic review and meta-analysis. PLoS One. 8:e646692013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gnecchi M, He H, Liang OD, et al:
Paracrine action accounts for marked protection of ischemic heart
by Akt-modified mesenchymal stem cells. Nat Med. 11:367–368. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Behfar A, Zingman LV, Hodgson DM, Rauzier
J-M, Kane GC, Terzic A and Pucéat M: Stem cell differentiation
requires a paracrine pathway in the heart. FASEB J. 16:1558–1566.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Williams AR, Suncion VY, McCall F, Guerra
D, Mather J, Zambrano JP, Heldman AW and Hare JM: Durable scar size
reduction due to allogeneic mesenchymal stem cell therapy regulates
whole-chamber remodeling. J Am Heart Assoc. 2:e0001402013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Forest VF, Tirouvanziam AM, Perigaud C,
Fernandes S, Fusellier MS, Desfontis JC, Toquet CS, Heymann MF,
Crochet DP and Lemarchand PF: Cell distribution after intracoronary
bone marrow stem cell delivery in damaged and undamaged myocardium:
Implications for clinical trials. Stem Cell Res Ther. 1:42010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li W, Ma N, Ong LL, et al: Bcl-2
engineered MSCs inhibited apoptosis and improved heart function.
Stem Cells. 25:2118–2127. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Das H, George JC, Joseph M, et al: Stem
cell therapy with overexpressed VEGF and PDGF genes improves
cardiac function in a rat infarct model. PLoS One. 4:e73252009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pipes GC, Creemers EE and Olson EN: The
myocardin family of transcriptional coactivators: Versatile
regulators of cell growth, migration, and myogenesis. Genes Dev.
20:1545–1556. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Miano JM: Serum response factor: toggling
between disparate programs of gene expression. J Mol Cell Cardiol.
35:577–593. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang D, Chang PS, Wang Z, Sutherland L,
Richardson JA, Small E, Krieg PA and Olson EN: Activation of
cardiac gene expression by myocardin, a transcriptional cofactor
for serum response factor. Cell. 105:851–862. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mikhailov AT and Torrado M: In search of
novel targets for heart disease: Myocardin and myocardin-related
transcriptional cofactors. Biochem Res Int. 2012:9737232012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cao XL, Hu XM, Hu JQ and Zheng WX:
Myocardin-related transcription factor-A promoting neuronal
survival against apoptosis induced by hypoxia/ischemia. Brain Res.
1385:263–274. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Latif N, Sarathchandra P, Chester AH and
Yacoub MH: Expression of smooth muscle cell markers and
co-activators in calcified aortic valves. Eur Heart J.
36:1335–1345. 2015. View Article : Google Scholar
|
|
19
|
Liao XH, Wang N, Liu QX, Qin T, Cao B, Cao
DS and Zhang TC: Myocardin-related transcription factor-A induces
cardiomyocyte hypertrophy. IUBMB Life. 63:54–61. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Small EM, Thatcher JE, Sutherland LB,
Kinoshita H, Gerard RD, Richardson JA, Dimaio JM, Sadek H, Kuwahara
K and Olson EN: Myocardin-related transcription factor-a controls
myofibroblast activation and fibrosis in response to myocardial
infarction. Circ Res. 107:294–304. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Parmacek MS: Myocardin-related
transcription factor-A: mending a broken heart. Circ Res.
107:168–170. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Guo J, Li HZ, Wang LC, Zhang WH, Li GW,
Xing WJ, Wang R and Xu CQ: Increased expression of calcium-sensing
receptors in atherosclerosis confers hypersensitivity to acute
myocardial infarction in rats. Mol Cell Biochem. 366:345–354. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao SL, Zhang YJ, Li MH, Zhang XL and
Chen SL: Mesenchymal stem cells with overexpression of midkine
enhance cell survival and attenuate cardiac dysfunction in a rat
model of myocardial infarction. Stem Cell Res Ther. 5:372014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sacherer M, Sedej S, Wakuła P, et al:
CONTICA investigators: JTV519 (K201) reduces sarcoplasmic reticulum
Ca2+ leak and improves diastolic function in
vitro in murine and human non-failing myocardium. Br J Pharmacol.
167:493–504. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cai BZ, Meng FY, Zhu SL, et al: Arsenic
trioxide induces the apoptosis in bone marrow mesenchymal stem
cells by intracellular calcium signal and caspase-3 pathways.
Toxicol Lett. 193:173–178. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gao YS, Ding H, Xie XT and Zhang CQ:
Osteogenic induction protects rat bone marrowederived mesenchymal
stem cells against hypoxia-induced apoptosis in vitro. J Surg Res.
184:873–879. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ning J, Li C, Li H and Chang J: Bone
marrow mesenchymal stem cells differentiate into urothelial cells
and the implications for reconstructing urinary bladder mucosa.
Cytotechnology. 63:531–539. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gnecchi M, Danieli P and Cervio E:
Mesenchymal stem cell therapy for heart disease. Vascul Pharmacol.
57:48–55. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Clifford D, Fisher S, Brunskill S, Doree
C, Mathur A, Watt S and Martin-Rendon E: Stem cell treatment for
acute myocardial infarction. Cochrane Database Syst Rev.
2:CD0065362012.PubMed/NCBI
|
